A critical breakthrough in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently lost in various types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research